CAAS Capital Management’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,724
Closed -$1K 1068
2022
Q3
$1K Hold
13,724
﹤0.01% 817
2022
Q2
$1K Hold
13,724
﹤0.01% 874
2022
Q1
$3K Buy
+13,724
New +$5.69K ﹤0.01% 625

CAAS Capital Management's SSAAW Position: Q4 2022 in Review

CAAS Capital Management sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q4 2022, closing a stake of 13,724 shares — an estimated $1K sold.

CAAS Capital Management first reported a position in SSAAW in Q1 2022 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 0 funds tracked by Wall St. Rank hold SSAAW as of Q4 2022.

  • CAAS Capital Management reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q4 2022 after selling out during the quarter.
  • CAAS Capital Management sold 13,724 Science Strategic Acquisition Corp. Alpha Warrant shares in Q4 2022, an estimated $1K.
  • CAAS Capital Management first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q1 2022 and held it in 3 quarters.
  • CAAS Capital Management's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $3K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.